Dr. Pin Wang | Neuroimmunology | Best Researcher Award
Dr. Pin Wang, a female medical doctor and postdoctoral researcher, is an Associate Chief Physician in Neurology at the Second Hospital of Shandong University. She earned her PhD in Neurology from Shandong University in 2009 and was a visiting scholar at the NIH, USA. She specializes in neuroimmunology, focusing on multiple sclerosis and related disorders. Dr. Wang has led research funded by the Shandong Natural Science Foundation and the Department of Education, with multiple SCI-indexed publications.
Profile
Education š
Dr. Wang obtained her PhD in Neurology from Shandong University School of Medicine in 2009. From 2012 to 2013, she trained at the National Institute of Neurological Disorders and Stroke (NINDS), NIH, under Dr. Bibiana Bielekova, focusing on immune-mediated neurological diseases. Her education integrates clinical neurology, research, and teaching, positioning her as an expert in demyelinating diseases and neuroimmune disorders.
Experience šØāš«
Dr. Wang has extensive experience in neurology, combining clinical practice, teaching, and research. She worked at NIH, studying neuroimmune disease mechanisms and participated in the FDA-approved daclizumab clinical trials for multiple sclerosis. She is an Associate Chief Physician at Shandong Universityās Second Hospital and actively contributes to patient care, student training, and neurological research, particularly in neuroimmunology.
Research Interests š¬
Dr. Wang has received funding from the Shandong Natural Science Foundation and the Department of Education for her research in neurological disorders. Her contributions to neuroimmunology have been recognized through multiple SCI publications and conference presentations. She plays an active role in professional neurology and immunology committees in Shandong Province.
Publications š
-
Integrating lanthanide coordination polymer ratiometric fluorescence biosensors with a concatenated DNA circuit for locus-specific N6-methyladenosine quantification
Chemical Communications,Ā 2025